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Abstract
Background: Accurate assessment of suicidality is of major importance. We aimed to evaluate
trained clinicians' ability to assess suicidality against a structured assessment made by trained raters.
Method:  Treating clinicians classified 218 adolescent psychiatric outpatients suffering from a
depressive mood disorder into three classes: 1-no suicidal ideation, 2-suicidal ideation, no suicidal
acts, 3-suicidal or self-harming acts. This classification was compared with a classification with
identical content derived from the Kiddie Schedule for Affective Disorders and Schizophrenia (K-
SADS-PL) made by trained raters. The convergence was assessed by kappa- and weighted kappa
tests.
Results: The clinicians' classification to class 1 (no suicidal ideation) was 85%, class 2 (suicidal
ideation) 50%, and class 3 (suicidal acts) 10% concurrent with the K-SADS evaluation (γ2 = 37.1, df
4, p = 0.000). Weighted kappa for the agreement of the measures was 0.335 (CI = 0.198–0.471, p
< 0.0001). The clinicians under-detected suicidal and self-harm acts, but over-detected suicidal
ideation.
Conclusion:  There was only a modest agreement between the trained clinicians' suicidality
evaluation and the K-SADS evaluation, especially concerning suicidal or self-harming acts. We
suggest a wider use of structured scales in clinical and research settings to improve reliable
detection of adolescents with suicidality.
Background
Suicide is a major cause of mortality among adolescents;
it has been estimated that up to 25% of young people
have had suicidal ideation, and approximately 2–12%
have attempted suicide at some time in their lives [1].
Standardized clinical assessments of adolescent outpa-
tient samples have revealed that up to 60% have suicidal
ideation, and up to 20% have made suicide attempts
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[2,3]. In a sample of adolescent depressed outpatients
more than half had made suicide attempts [4]. According
to a review by Safer [5] anonymous surveys of suicidal
behavior have yielded lifetime prevalences of 7% to 10%
for adolescents, whereas studies using structured inter-
views have found lifetime prevalences of 3% to 4%.
Regardless of the great variability in the estimations of its
prevalence, suicidality in its different forms seems surpris-
ingly prevalent in the adolescent general population. Ado-
lescent suicide occurs mostly in the context of an active,
often treatable, but unrecognized or untreated mental ill-
ness, such as depression or substance abuse [6,7]. The
increase in antidepressant treatments of adolescents [8]
have been suggested to at least partly explain the decline
in the incidence of suicide [9] in many Western countries
during the past decade. Recently, though, some reports
have connected SSRI-treatment in adolescents to an
increase in suicidality [10,11].
Suicide attempts are complex acts for which no single set
of clinical characteristics can be expected to be a good pre-
dictor [12,13]. Although the domain of suicidal behavior
is multidimensional [14], a continuum from suicide idea-
tion to suicide attempts has been reported in clinical ado-
lescent populations [15,3,16]. Although only a minority
of patients with suicidal ideation attempt suicide, and
only a minority of attempters die, a previous suicide
attempt has been shown to be one of the most significant
risk factors for suicide [17-19]. Research concerning the
role of suicidal ideation as a risk factor for suicide is less
consistent, but many studies suggest that suicidal ideation
predicts suicide attempts and suicides [e.g. [2,20,21]].
Thus, accurate assessment of suicidality is of major impor-
tance in both clinical and research settings.
The ability of clinicians to evaluate suicidality has been
addressed in a few publications. Pelkonen et al. [22], for
example, found that previous and current suicidal behav-
ior was more common than referring persons were able to
recognize, and could be detected by the clinician's system-
atic, structured, and documented inquiring about suicid-
ality of all adolescent psychiatric outpatients. In a study by
Malone et al. [23] fewer suicide attempts were clinically
reported than in concurrently and independently com-
pleted research data. These studies suggest that a signifi-
cant degree of past and present suicidal behavior is not
recognized and recorded during routine clinical assess-
ment. Thus, easy-to-use instruments are needed to
improve the clinicians' ability to recognize suicidality.
Numerous instruments have been developed with the aim
of measuring different factors involved in the complex
clinical task of suicide risk evaluation, but the use of them
is often restricted to research settings [14]. A three-class
mutually exclusive grouping of suicidality (non-suicidal,
suicide ideation, suicide attempts) assessed by a clinician
is a simplified version of the 5-item "Spectrum of Suicidal
Behavior Scale" [24,25], and has previously been used in
both research and clinical settings [3]. It consists of two
structured questions, which are asked during a routine
clinical interview, and the documentation of the answers
to them. There is some evidence supporting the predictive
validity of this grouping [3] but there have never been
attempts to compare it with more structured measures.
We aimed to evaluate this simple and straightforward
assessment of suicidality by training clinicians to ask
about suicidality and document the answers, and com-
pare this data with data obtained from the suicidality
items of the K-SADS-PL Screen Interview. Although we
expected these measures to converge with each other, we
hypothesized that the clinical evaluation might under-
detect suicidality compared with the structured assess-
ment performed by trained raters.
Methods
Subjects
The subjects were 218 adolescent psychiatric outpatients.
They suffered from depressive mood disorder, were of
ages 13 – 19, and took part in the Adolescent Depression
Study (ADS [26,27] karlsson et al 2008). They were
recruited between March 1st, 1998 and December 31st,
2001 from a consecutive sample of patients attending the
outpatient clinics of the Department of Adolescent Psy-
chiatry of Peijas Medical Health Care District (PMCD)
covering approximately 210,000 inhabitants and com-
prising the cities of Vantaa and Kerava in the Helsinki
metropolitan area, Southern Finland. Of the eligible
(appropriate age, knowledge of Finnish language, and
adequate cognitive capacity) 660 outpatients, 624
(94.5%) were screened by the Beck Depression Inventory
(BDI) [28] and the General Health Questionnaire-36
(GHQ-36) [29,30] during their first consultation visit.
373 patients (59.8%) with scores of 10 or more and 5 or
more, respectively, were considered screen positive, and
were asked to participate in the study. 118 (31.6%) outpa-
tients refused to participate and 34 (9.1%) dropped out at
this stage. 221 (33.5%) remaining outpatients were eval-
uated by a diagnostic interview (K-SADS-PL) [31]; 218
(33.0%) with a current depressive mood disorder were
included in the study. A written informed consent was
obtained from the subjects. For subjects less than 18 years
old consent was asked from parents or other legal guardi-
ans. The study protocol was accepted by the ethics com-
mittees of Helsinki University Central Hospital and
PMCD.
Measurements
1. Clinicians' suicidality assessment (CSA), a three-point
mutually exclusive grouping of suicidality (1-non-sui-BMC Psychiatry 2008, 8:97 http://www.biomedcentral.com/1471-244X/8/97
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cidal, 2-suicide ideation, 3-suicide attempts) is a simpli-
fied version of the 5-item "Spectrum of Suicidal Behavior
Scale" [24,25]. It has been used for both research and clin-
ical purposes [3]. The grouping is done by a clinician, and
is based on two simple questions "Have you thought of
killing yourself?" and "Have you attempted suicide?" and
on patient records when appropriate. In this study, after a
brief training, the treating clinicians of the outpatient clin-
ics made the clinical suicidality assessment. They were
instructed to include in class 3 also self-mutilation and
other self-harming behavior whether or not actual suicide
intent was evident.
2. K-SADS-PL: The Kiddie Schedule for Affective Disorders
and Schizophrenia for School-Aged Children-Present and
Lifetime (K-SADS-PL) [31] is a widely used semi-struc-
tured diagnostic interview with fairly good psychometric
properties [31,32]. It is considered an internationally reli-
able and valid diagnostic instrument for adolescent popu-
lation [33]. K-SADS-PL has been translated into Finnish
and then back translated to confirm accuracy of transla-
tion. It has been used in numerous studies on adolescents
in Finland [e.g. [34]]. In this study the five items concern-
ing suicidal ideation and behavior of the Screen Interview
of the K-SADS-PL were used as the standard for assessing
suicidality. The items inquire about thoughts of death
(item 1), suicidal ideation (item 2), presence of suicide
attempts (item 3), non-suicidal self-harming behavior
(item 4), and medical lethality and intent associated with
the possible suicide attempt (item 5). Each item is scored
using a 0- to 3-point rating scale. Score of 0 indicates that
no information is available, a score of 1 suggests the
symptom is not present, a score of 2 indicates sub-thresh-
old level of the symptom, and a score of 3 indicates
threshold criterion. Nine trained raters, who were also
experienced clinicians, did the rating. Inter-rater reliabil-
ity, assessed using 15 randomly selected videotaped inter-
views, was good for mood disorder diagnoses [weighted
kappa [35] for MDD, other mood disorder, no mood dis-
order 0.87 (95% CI = 0.81–0.93)].
Procedures
Both assessments were performed at the beginning of
treatment in an outpatient clinic, and the time frame for
suicidality for both instruments was the preceding 2
weeks. To enable a meaningful comparison between the
two instruments, the results of the K-SADS-PL were forced
into three classes identical to the above-mentioned clini-
cal suicidality assessment as follows: Class 1 – no suicidal
ideation in K-SADS-PL item 1 and 2; Class 2 – suicidal ide-
ation in K-SADS-PL item 1 or 2, but no suicidal or self-
harming acts according to K-SADS-PL items 3–5; Class 3 –
suicidal or self harming acts according to K-SADS items 3–
5, regardless of the score in item 1 and 2. Only scores of 3
in each item indicating presence of threshold criterion
were counted. This procedure ensured that the three-class
classification with increasing severity of suicidality by the
two instruments was practically identical in their content.
Two comparisons were made, with two different K-SADS-
PL definitions of suicidal ideation: 1) with thoughts of
death not included in suicidal ideation, and 2) with
thoughts of death included in suicidal ideation.
The K-SADS-PL results of the cases that were classified
inconsistently by the two measures were explored item by
item. Lifetime suicidal or self-harming acts detected clini-
cally (from the patient records) and by the K-SADS-PL
were estimated and compared.
Statistical analysis
The convergence in the classification by the two measures
was calculated by Kappa (κ) and weighted kappa analysis
[35]. The sensitivity and the specificity of the CSA to rec-
ognize suicidality were assessed against the K-SADS-PL.
Statistical analyses were performed by the SPSS 11.0 [36].




All the subjects were classified by both the CSA and the K-
SADS-PL. The subjects' mean age was 16.4 (SD 1.6), 18%
(n = 40) were boys and 82% (n = 178) girls. The median
interval between the two measurements was 6 days (range
0–35). The interval did not influence the correlation
between the measurements (r = .369, p = .000 vs. r = .364,
p = .000). Thirty (13.8%) subjects were classified by the K-
SADS-PL as having had suicidal or self-harming acts
(Class-3) during the past two weeks, 32 (14.7%) as having
suicidal ideation (Class-2), and 156 (71.6%) as having no
suicidality (Class-1). After including recurrent thoughts of
death, suicidal ideation was present in 52 (23.9%) sub-
jects.
Convergence of the measurements
Seventy percent (n = 152) of the subjects were classified
identically by the two three-class suicidality assessments
(χ2 = 57.8, df 4, p = 0.000). Weighted kappa [35] for the
agreement of the two classifications was 0.335 (95% CI =
0.198–0.471, p < 0.0001). Kappa on the agreement about
any form of suicidality was 0.404 (p < 0.0001). In a com-
parison between CSA and the K-SADS-PL classification
with thoughts of death included in suicidal ideation
67.4% (n = 147) of the subjects were classified identically
(χ2 = 44.5, df 4, p = 0.000, weighted κ = 0.346, 95% CI =
0.215–0.492, p < 0.0001). Comparisons of the classifica-
tions are presented in Table 1.BMC Psychiatry 2008, 8:97 http://www.biomedcentral.com/1471-244X/8/97
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Validity coefficients
The sensitivity and specificity of CSA in recognizing any
suicidality (thoughts or acts) were 51.6% and 85.3%,
respectively, using K-SADS-PL (without thoughts of death
in suicidal ideation) as the standard. The sensitivity and
specificity of CSA in recognizing suicidal or self-harming
acts were 10% and 98.9%, respectively. Twenty-one
(77.8%) of the 27 K-SADS-PL class-3 cases missed by the
CSA had non-suicidal self-harming and suicidal acts, as
thirteen of them were reported having had only non-sui-
cidal self-harming without suicidal acts.
Lifetime suicidality
Seventy-eight (35.8%) subjects by the K-SADS-PL and 100
(45.9%) subjects by clinical records were classified as hav-
ing had suicidal or self-harming behavior during their life-
time. The convergence between these estimates was
significant (χ2 = 143.3 df 1 p = 0.000, κ = 0.79) although
22 (10.1%) patients were classified incorrectly.
Discussion
In order to improve the clinicians' ability to detect suicid-
ality, we trained them to ask about suicidality and to doc-
ument the answers. This study assessed the utility of this
simple and straightforward 3-class clinical suicidality
assessment against a semi-structured diagnostic interview
(K-SADS-PL). We found that although the classifications
converged significantly, the agreement between these two
ways of evaluating suicidality, especially concerning sui-
cidal or self-harming acts, was not satisfactory.
Suicidal acts and self-harming
Over 3/4 of the suicidal subjects, undetected by the clini-
cians, had self-harming acts, about half of them having
self-harm without suicidal acts. According to this study,
deliberate self-harm without clear suicidal intention
seems especially difficult for clinicians to detect using the
crude "suicidal acts" classification. Furthermore, our
results suggest that self-harm may even lead to under-
detection of co-occurring suicidal acts. It is possible that
self-harm may not be regarded as "true suicidality" (either
by the patient or by the clinician), and it may "mask" sui-
cidal acts from the clinician. Deliberate self-harm may be
under-recognized by the treating personnel, unless it is
specifically inquired [22], as adolescents tend not to
inform others of it [38]. Adolescent patients may underre-
port suicidality, especially deliberate self-harm due to
concerns about confidentiality [5]. Questionnaires or rat-
ing scales with a rater from outside the treatment team
may be needed for appropriately sensitive detection of
suicidal or self-harming acts.
Lifetime suicide attempts
The K-SADS-PL, although detecting current suicidality,
seems not to reliably detect lifetime suicidality, as it did
not recognize 10% of subjects with suicidal behavior doc-
umented in patient records. This may be due to the fact
that the suicidality items are inquired with questions con-
cerning mood disorder episodes, and the most severe epi-
sode may not be the most suicidal if for example the
patient has impulsive traits.
Suicidal ideation
Different from self-harming, our results suggest that clini-
cians' evaluation over-detects suicidal ideation compared
with the K-SADS-PL. Over 1/3 of the subjects over-
detected by the clinicians had thoughts of death, and the
rest had sub-threshold suicidal ideation. In clinical prac-
tice, accurate ruling out of thoughts of death with no
thoughts of suicide may be difficult and may lead to over-
detection of suicidal ideation. Clinicians may see
thoughts of death as a form of suicidality that must be
taken seriously. It may also be that thoughts of death
could best be conceived as a mild form of suicidal idea-
tion with a better prognosis than severe ideation [2]. Our
results support this view, as after including thoughts of
death in suicidal ideation of the K-SADS-PL there was a
better convergence between the two instruments in detec-
tion of that form of suicidality. The overall convergence of
the instruments did not improve, however, as the clini-
cians under-detected many subjects having thoughts of
death.
The results suggest that K-SADS-PL diagnostic threshold
for suicidal ideation may be too high; over half of the
cases over-detected by the clinicians had sub-threshold
suicidal ideation. K-SADS-PL classifies occasional
thoughts of suicide without planning as sub-threshold
Table 1: Convergence of three-class clinical suicidality assessment (CSA) made by treating clinician and K-SADS-PL suicidality scoring 
performed by trained rater in 218 adolescent outpatients with a mood disorder.
K-SADS-PL
No suicidality Suicidal ideation Suicidal acts TOTAL
CSA – no suicidality 133 (121) 15 (27) 15 163
CSA – suicidal ideation 22 (14) 16 (24) 12 50
CSA-suicidal acts 1 (1) 1 (1) 3 5
TOTAL 156 (136) 32 (52) 27 218
(comparison with K-SADS-PL detected thoughts of death included in suicidal ideation is in parentheses).BMC Psychiatry 2008, 8:97 http://www.biomedcentral.com/1471-244X/8/97
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suicidal ideation; frequent thoughts and planning are
required to pass the threshold. Principally, sub-threshold
suicidal ideation in the K-SADS-PL would qualify as sui-
cidal ideation in the clinicians' evaluation that does not
inquire about frequency. Thus, the over-detection of sui-
cidal ideation by clinicians may be caused by the different
thresholds and criteria of the two measures.
Methodological concerns
1) The clinicians' evaluation here was based on two sim-
ple questions with good face validity, it was non-struc-
tured and naturalistic, and the classification is simple.
However, there are some problems with this evaluation
that deserve attention. First, in order to detect suicidal acts
and self-harming more accurately a separate question for
self-harming/self-mutilation with no suicidal intent may
be needed. The assessment of intention of a suicide
attempt is especially difficult in adolescents as they may
not correctly perceive the lethality of their attempt [39].
Secondly, a more specific question or a higher threshold
for the clinicians' inquiry about suicidal ideation may be
needed, as they also seem to rate sub-threshold suicidal
ideation as clinically significant.
2) The standard for suicidality detection in this study was
the K-SADS-PL, which has a good face validity and satis-
factory inter-rater reliability [32], but not enough overall
psychometric support yet. Moreover, it has not yet been
used widely in studies of suicidal behavior [40]. The K-
SADS-PL was forced into three classes that suited the clini-
cians' evaluation well in their content. Expectedly, consid-
ering or not considering thoughts of death as suicidal
ideation in the classification somewhat changed the con-
vergence between the K-SADS-PL and the clinical rating.
Our results suggest that the current diagnostic K-SADS-PL
threshold for suicidal ideation may need adjustment
downwards. According to our findings, the K-SADS-PL in
its present form may underestimate lifetime suicidal acts
or self-harming behavior. This may be due to its emphasis
on episodes of mood disorders, which may not always be
those with the most severe suicidality. In any case, studies
on the reliability and validity of the assessment of suicid-
ality using the K-SADS-PL are needed. As this study was
cross-sectional it could not evaluate the crucial aspect of
predictive validity in detecting suicidality.
3) Although large and representative, the sample was a
pure outpatient sample, and females were over-repre-
sented. With inpatients included in the sample, we would
probably have seen a somewhat wider spectrum of suicid-
ality. As the sample was limited to an urban area in south-
ern Finland, the generalizability of our findings to rural
areas, or to other countries, is not known. Although the
time frame for the two measurements was very similar, it
was not identical, and this may cause some of the discrep-
ancy. The screening performance of our measures may not
be generalized into adult populations. Self-report ques-
tionnaires may be more sensitive in detecting suicidality
in adolescent population because of confidentiality
issues.
Conclusion
This report compared clinical evaluation with structured
evaluation in the detection of suicidality in a clinical pop-
ulation of adolescents, and brought valuable information
concerning these different but commonly used ways of
detecting suicidality. From the point of view of a clinician,
it seems important that a measure of suicidality is sensi-
tive in finding any suicidality. However, a good measure
should detect also subjects with especially high risk in
order to supply special interventions. The relation of
thoughts of death and non-suicidal self-harming behavior
to suicidality remains open and warrants further research.
Studies on predictive validity would shed light on topics
like the association of appropriate thresholds and differ-
ent sub-threshold forms of suicidality to suicides and sui-
cide attempts. Our results suggest that structured
instruments are needed for appropriately sensitive detec-
tion of suicidal or self-harming acts and specific recogni-
tion of real suicidal ideation. We suggest that continuous
training in inquiring about and detecting suicidality is
needed in order to recognize subjects with suicidal acts
and especially subjects with self-harming behavior. Fur-
thermore, the development of simple and reliable meas-
ures of suicidality, which could easily be used by
clinicians, is of major importance.
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